trial · primary record
Adagrasib
Solid Tumors
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 170 |
| Primary completion | 2028-02-16 |
| Primary endpoint | Number of Participants With Adverse Events (AEs) |
| Registry ID | NCT07415031 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:31.268Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07415031
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.